Advertisement
The 9th International Congress of the Immunology of Diabetes Society (IDS)and American Diabetes Association (ADA) Research Symposium
Advertisement
International researchers will meet November 14-18 to discuss the latestscience and theories in type 1 diabetes research. IDS is an internationalcollaboration created to advance research in the etiology, pathogenesis,prevention and cure of type 1 diabetes. A key area of focus is clinical trialsto alter the type 1 diabetes disease process, eventually leading to preventionof this disease. ADA's mission is to prevent and cure diabetes and to improvethe lives of all people affected by diabetes.BETHESDA, Md., Nov. 13 /PRNewswire/ -- WHAT: On World Diabetes Day, November 14, leaders in type 1 diabetes research will present their findings to the media via teleconference. These scientists represent two international groups of type 1 diabetes researchers meeting in Miami during the week of November 14 to share their latest findings and plan future research. WHEN: November 14, 2007, 12:00 - 1:30 p.m. (EST) Four experts will make 15-minute presentations, followed by a 30- minute Q&A. WHY: This media teleconference presents an outstanding opportunity for you to get an update on exciting type 1 diabetes research and advances, as you put together stories for your readers during American Diabetes Month in November. -- Type 1 diabetes is increasing every year, reaching epidemic proportions in some countries, with the greatest increase in children under age 5. In response to this phenomenon, diabetes researchers across the globe have been working to advance the study, prevention and treatment of type 1 diabetes. As a result, the way we detect and treat diabetes is dramatically changing. A simple blood test can now identify the autoantibodies for type 1 diabetes up to 10 years before diagnosis. -- If diabetes can be delayed, even for a few years, those at risk may be able to postpone the difficult challenges of controlling their glucose levels and the development of serious complications. The serious complications of diabetes include heart disease, stroke, blindness, kidney damage and lower-limb amputations. PANEL TOPICS & PRESENTERS: Advances in the Prevention and Reversal of Type 1 Diabetes Jay Skyler, MD, MACP, University of Miami Chairman of Type 1 Diabetes TrialNet and Professor at the internationally renowned University of Miami's Diabetes Metabolic Unit, Dr. Skyler will give an overview of the current advances and planned research efforts toward finding ways to prevent and reverse type 1 diabetes. Nasal Insulin and Prevention of Type 1 Diabetes Olli Simell, MD, PhD, University of Turku, Finland Physician, researcher, and instructor of international stature, Dr. Simmel will provide an overview of a study testing nasal insulin to prevent type 1
